Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine for chronic stable angina (Phase II, China)
CTR20150159Phase 2Active
- Sponsor
- Xi'an Xintong Pharmaceutical Research Co., Ltd.
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ivabradine in angina pectoris, sponsored by Xi'an Xintong Pharmaceutical Research Co., Ltd.. Started Feb 2016; status: active.
02
Drugs
ivabradine
03
Conditions
angina pectoris
Beyond the preview
Go deeper on CTR20150159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150159.